| Autor: |
A.S. Cholak, I.O. Nasinnyk, P.O. Kostenko, S.A. Iakimenko, A.R. Korol |
| Jazyk: |
English<br />Ukrainian |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Journal of Ophthalmology, Iss 1, Pp 54-56 (2020) |
| Druh dokumentu: |
article |
| ISSN: |
2412-8740 |
| DOI: |
10.31288/oftalmolzh202015456 |
| Popis: |
Background: Corneal neovascularization (CNV) is a serious condition that can lead to a profound decline in vision. Current research on treating CNV with angiogenesis inhibitors is underway in numerous centers, and a number of studies have demonstrated the efficacy of this approach. Purpose: To present a case of corneal neovascularization treated with aflibercept. Material and Methods: An ocular examination included visual acuity assessment, biomicroscopy, anterior eye photography and fluorescein angiography (FA). In addition, an area of CNV was assessed before and 6 months after a single subconjunctival injection of 4 mg (0.1ml) aflibercept. Results: An area of CNV decreased from 38,081 pixels before injection to 20,782 at 6 months, with a reduction in 17,299 pixels. Conclusion: In the case reported here, a single subconjunctival injection of 4 mg (0.1ml) aflibercept was found to be effective for reducing corneal neovascularization at 6 weeks. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
